Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 63,324 | 58,451 | 50,831 | 40,985 |
| Marketable securities, current | 152,826 | 177,431 | 197,498 | 221,586 |
| Prepaid expenses and other current assets | 4,809 | 5,537 | 3,999 | 4,175 |
| Total current assets | 220,959 | 241,419 | 252,328 | 266,746 |
| Property and equipment, net | 2,071 | 2,225 | 2,144 | 2,246 |
| Marketable securities, noncurrent | 73,781 | 74,420 | 76,671 | 74,699 |
| Restricted cash | 963 | 963 | 962 | 962 |
| Operating lease right-of-use asset | 6,680 | 6,926 | 7,165 | 7,395 |
| Other assets | 585 | 0 | 0 | 0 |
| Total assets | 305,039 | 325,953 | 339,270 | 352,048 |
| Accounts payable | 2,109 | 769 | 1,481 | 914 |
| Accrued expenses | 6,328 | 9,668 | 6,929 | 5,468 |
| Operating lease liability, current | 1,322 | 1,269 | 1,217 | 1,168 |
| Other current liabilities | 17 | 6 | 224 | NaN |
| Total current liabilities | 9,776 | 11,712 | 9,851 | 7,550 |
| Operating lease liability, noncurrent | 7,055 | 7,408 | 7,751 | 8,069 |
| Total liabilities | 16,831 | 19,120 | 17,602 | 15,619 |
| Convertible preferred stock, value-Series Seed Convertible Preferred Stock | NaN | 0 | 0 | 0 |
| Convertible preferred stock, value-Series AConvertible Preferred Stock | NaN | 0 | 0 | 0 |
| Convertible preferred stock, value-Series BConvertible Preferred Stock | NaN | 0 | 0 | 0 |
| Convertible preferred stock, value-Series CConvertible Preferred Stock | NaN | 0 | 0 | 0 |
| Convertible preferred stock, value | NaN | 0 | 0 | 0 |
| Common stock, 0.001 par value, 500,000,000 shares authorized as of march31, 2026 and december31, 2025, respectively 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of march31, 2026 and december31, 2025, respectively | 45 | 45 | 44 | 44 |
| Additional paid-in capital | 571,380 | 562,602 | 557,118 | 551,838 |
| Accumulated other comprehensive (loss) income | -84 | 540 | 420 | 183 |
| Accumulated deficit | -283,133 | -256,354 | -235,914 | -215,636 |
| Total stockholders equity | 288,208 | 306,833 | 321,668 | 336,429 |
| Total liabilities and stockholders equity | 305,039 | 325,953 | 339,270 | 352,048 |